Formulation and manufacturing patents have become core lifecycle-management tools, with polymorph strategies underpinning ~68% of newly approved solid small-molecule drugs in 2024. Continuous-flow and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results